Objective:To confirm the safety and nutritional efficacy of ClinOleic 20% through a pragmatic study allowing its use as an alternative to Intralipid 20%. Methods:The study was performed as a multicenter,randomized,doubleblinded,prospective,noninferiority trial.Two hundred and five patients undergoing moderate abdominal surgery were randomly assigned to receive ClinOleic 20% and Intralipid 20% as part of their TPN regimen over 5 days.Daily parenteral intakes of energy nitrogen and lipid were equal in two groups.The nutrition regimen was given as an allinone mixture,delivered continuously over 20 hours per day for 5 consecutive days. Results:Efficacy analysis showed that ClinOleic can be considered as efficient as Intralipid in providing energy to maintain albumin plasma concentrations.No serious adverse event was reported in the two groups.For hematology,renal,hepatic safety criteria and vital signs,no significant difference was observed between groups.No significant difference was observed concerning Cholesterol.For triglycerides, a statistically significant difference was observed between ClinOleic and Intralipid groups but the difference was not medically relevant and the means remained within the normal range. Conclusion:ClinOleic is a new safe and efficient lipid emulsion for parenteral nutrition.